Show simple item record

dc.contributor.authorNeller, Michelle A
dc.contributor.authorLopez, J Alejandro
dc.contributor.authorSchmidt, Christopher W
dc.date.accessioned2017-05-03T15:27:30Z
dc.date.available2017-05-03T15:27:30Z
dc.date.issued2008
dc.date.modified2009-12-08T07:55:59Z
dc.identifier.issn1044-5323
dc.identifier.doi10.1016/j.smim.2008.09.006
dc.identifier.urihttp://hdl.handle.net/10072/22378
dc.description.abstractProgress in tumor immunology has not been translated to effective immunotherapies for cancer. Most of the current effort in basic and clinical research concentrates on generating effective immune responses against model or well characterized antigens, yet vaccines targeting defined antigens have been less clinically successful than those based on whole tumor cells or their extracts. This review considers characteristics of proteins that determine how effectively they might serve as targets of immune control, and how different sources of antigens have fared in clinical trials.
dc.description.peerreviewedYes
dc.description.publicationstatusYes
dc.languageEnglish
dc.language.isoeng
dc.publisherAcademic Press
dc.publisher.placeUnited Kingdom
dc.publisher.urihttp://www.sciencedirect.com/science/journal/10445323
dc.relation.ispartofstudentpublicationN
dc.relation.ispartofpagefrom286
dc.relation.ispartofpageto295
dc.relation.ispartofjournalSeminars in Immunology
dc.relation.ispartofvolume20
dc.rights.retentionY
dc.subject.fieldofresearchImmunology
dc.subject.fieldofresearchcode3204
dc.titleAntigens for cancer immunotherapy
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.date.issued2008
gro.hasfulltextNo Full Text
gro.griffith.authorLopez Ramirez, Alejandro


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record